DRGs-PPS下的临床药师参与股骨颈骨折临床路径的实施效果

发布时间：2018-02-24 02:09

  本文关键词： 临床路径 临床药师 股骨颈骨折 药学干预 疾病诊断相关组预付费制度　出处：《中国药房》2017年23期 　论文类型：期刊论文

【摘要】：目的:探讨在疾病诊断相关组预付费制度(DRGs-PPS)下的临床药师参与股骨颈骨折临床路径的实施效果,为促进临床合理用药提供参考。方法:收集我院进入临床路径的股骨颈骨折患者作为研究对象。2015年1-12月的患者为对照组,入径52例,完成路径41例;2016年1-12月的患者为观察组,入径58例,完成路径46例。临床药师参与观察组患者的临床路径实施,对临床用药进行技术干预和行政干预,对照组未进行干预。观察两组患者住院时间、住院费用、药品费用及不良反应情况,并比较两组患者预防用抗菌药物、镇痛药、辅助用药、抗骨质疏松药、抗凝药等5类药物的合理性。结果:临床药师参与观察组临床路径实施后,两组患者住院时间和不良反应发生率比较,差异均无统计学意义(P0.05);观察组患者的住院费用、药品费用显著低于对照组,差异均有统计学意义(P0.05)。观察组患者预防用抗菌药物的用药时间和费用、镇痛药的用药费用、辅助用药的用药时间显著低/短于对照组,抗骨质疏松药用药品种均显著多于对照组,差异均有统计学意义(P0.05)。结论:在DRGs-PPS下,临床药师参与股骨颈骨折临床路径的实施,在一定程度规范了我院骨科5类药物的用药合理性,确保骨科临床用药安全、有效、经济。
[Abstract]:Objective: to investigate the effect of clinical pharmacists involved in the clinical pathway of femoral neck fracture under the DRGs-PPSs system. Methods: the patients with femoral neck fracture who entered the clinical path in our hospital were collected as the research object. The patients from January to December of 2015 served as the control group, 52 patients with the route and 41 patients with the complete route, and the patients from January to December of 2016 as the observation group, and the patients from January to December of 2016 as the observation group. The clinical pharmacists participated in the implementation of the clinical pathway of the patients in the observation group, and carried out technical and administrative intervention on the clinical medication, while the control group did not intervene. The duration of hospitalization and the cost of hospitalization were observed in the two groups. The cost of drugs and adverse reactions were compared between the two groups. The rationality of 5 kinds of drugs such as antimicrobial drugs, analgesic drugs, adjuvant drugs, anti-osteoporosis drugs and anticoagulant drugs were compared between the two groups. Results: after the clinical pharmacists participated in the implementation of the clinical pathway in the observation group, There was no significant difference in the length of stay and the incidence of adverse reactions between the two groups (P 0.05), while the hospitalization cost and drug cost in the observation group were significantly lower than those in the control group. The difference was statistically significant (P 0.05). The time and cost of prophylactic use of antimicrobial agents, the cost of analgesics and the time of adjuvant medication in the observation group were significantly lower than those in the control group. The variety of anti-osteoporosis drugs was significantly more than that of the control group (P 0.05). Conclusion: under DRGs-PPS, the clinical pharmacists are involved in the implementation of the clinical pathway of femoral neck fracture. To a certain extent, the rationality of the use of 5 kinds of drugs in orthopedic department of our hospital is standardized to ensure the safety, efficiency and economy of clinical use of orthopedic drugs.
【作者单位】： 北京怀柔医院药剂科;
【分类号】：R683
，

本文编号：1528470